» Articles » PMID: 2294400

Developmental Regulation of Specific Protein Interactions with an Enhancerlike Binding Site Far Upstream from the Avian Very-low-density Apolipoprotein II Gene

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1990 Jan 1
PMID 2294400
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Expression of the avian very-low-density apolipoprotein II (apoVLDLII) gene is completely dependent on estrogen and restricted to the liver. We have identified binding sites for nonhistone nuclear proteins located between -1.96 and -2.61 kilobases. One of these sites, located at -2.6 kilobases (designated site 1), was found to span an MspI site that becomes demethylated between days 7 and 9 of embryogenesis, the stage of development at which competence to express the apoVLDLII gene begins to be acquired. Levels of the factor(s) involved were high at day 7 of embryogenesis, decreased two- to threefold by days 9 to 11, and continued to decline more slowly until hatching. Furthermore, the mobility of the complex formed underwent a well-defined shift between days 11 to 13 embryogenesis. Methylation interference studies showed that modification of the outer guanosines of the MspI site resulted in marked inhibition of the formation of the protein-DNA complex. Competition studies, fractionation of nuclear extracts, and tissue distribution indicated that the factor was not the avian homolog of hepatocyte nuclear factor 1, nuclear factor 1, or CCAAT/enhancer-binding protein (C/EBP). However, site 1 could complete for binding to an oligonucleotide, previously shown to be recognized by C/EBP, in a nonreciprocal fashion. These studies demonstrate that the sequence recognized by the protein includes a C/EBP consensus sequence but that elements in addition to the core enhancer motif are essential for binding.

Citing Articles

Cloning and characterization of chicken YB-1: regulation of expression in the liver.

Grant C, Deeley R Mol Cell Biol. 1993; 13(7):4186-96.

PMID: 8321222 PMC: 359968. DOI: 10.1128/mcb.13.7.4186-4196.1993.


Transcriptional regulation of the phosphoenolpyruvate carboxykinase gene by cooperation between hepatic nuclear factors.

Cohen H, Trus M, Aran A, Benvenisty N, Reshef L Mol Cell Biol. 1994; 14(11):7124-33.

PMID: 7935427 PMC: 359246. DOI: 10.1128/mcb.14.11.7124-7133.1994.


Isolation and characterization of the chicken homeodomain protein AKR.

Ryan A, Tejada M, May D, Dubaova M, Deeley R Nucleic Acids Res. 1995; 23(16):3252-9.

PMID: 7667102 PMC: 307185. DOI: 10.1093/nar/23.16.3252.


cIRF-3, a new member of the interferon regulatory factor (IRF) family that is rapidly and transiently induced by dsRNA.

Grant C, Vasa M, Deeley R Nucleic Acids Res. 1995; 23(12):2137-46.

PMID: 7541908 PMC: 307000. DOI: 10.1093/nar/23.12.2137.

References
1.
Hardon E, Frain M, Paonessa G, Cortese R . Two distinct factors interact with the promoter regions of several liver-specific genes. EMBO J. 1988; 7(6):1711-9. PMC: 457158. DOI: 10.1002/j.1460-2075.1988.tb03000.x. View

2.
Costa R, Grayson D, Xanthopoulos K, Darnell Jr J . A liver-specific DNA-binding protein recognizes multiple nucleotide sites in regulatory regions of transthyretin, alpha 1-antitrypsin, albumin, and simian virus 40 genes. Proc Natl Acad Sci U S A. 1988; 85(11):3840-4. PMC: 280315. DOI: 10.1073/pnas.85.11.3840. View

3.
Courtois G, Baumhueter S, Crabtree G . Purified hepatocyte nuclear factor 1 interacts with a family of hepatocyte-specific promoters. Proc Natl Acad Sci U S A. 1988; 85(21):7937-41. PMC: 282328. DOI: 10.1073/pnas.85.21.7937. View

4.
Baumhueter S, Courtois G, Crabtree G . A variant nuclear protein in dedifferentiated hepatoma cells binds to the same functional sequences in the beta fibrinogen gene promoter as HNF-1. EMBO J. 1988; 7(8):2485-93. PMC: 457118. DOI: 10.1002/j.1460-2075.1988.tb03095.x. View

5.
Schule R, Muller M, Kaltschmidt C, Renkawitz R . Many transcription factors interact synergistically with steroid receptors. Science. 1988; 242(4884):1418-20. DOI: 10.1126/science.3201230. View